At variance with the pro-angiogenic role of membrane-bound endoglin, soluble endoglin displays an anti-angiogenic activity [25, 27, 30], which has been postulated as a pathogenic contributor in preeclampsia [27]. This evidence concerns the gene ENG and preeclampsia.